Attention Deficit Hyperactivity Disorder (ADHD):グローバル臨床試験レビューH1, 2013...市場調査レポートについてご紹介

【英文タイトル】Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Attention Deficit Hyperactivity Disorder (ADHD) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 13
Top Five Countries Contributing to Clinical Trials in Europe 14
Top Countries Contributing to Clinical Trials in North America 15
Top Countries Contributing to Clinical Trials in Middle East and Africa 16
Top Five Countries Contributing to Clinical Trials in Central and South America 17
Clinical Trials by BRIC Nations 18
Clinical Trials by G7 Nations 19
Clinical Trials in G7 Nations by Trial Status 20
Clinical Trials by E7 Nations 21
Clinical Trials in E7 Nations by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Unaccomplished Trials of Attention Deficit Hyperactivity Disorder (ADHD) 26
Subjects Recruited Over a Period of Time 29
Prominent Sponsors 30
Top Companies Participating in Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Clinical Trials 32
Prominent Drug Comparison 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Eli Lilly and Company 35
Clinical Trial Overview of Eli Lilly and Company 35
Shire Plc 41
Clinical Trial Overview of Shire Plc 41
Johnson & Johnson 45
Clinical Trial Overview of Johnson & Johnson 45
Novartis AG 47
Clinical Trial Overview of Novartis AG 47
AbbVie Inc. 49
Clinical Trial Overview of AbbVie Inc. 49
New River Pharmaceuticals, Inc. 50
Clinical Trial Overview of New River Pharmaceuticals, Inc. 50
AstraZeneca PLC 51
Clinical Trial Overview of AstraZeneca PLC 51
Cephalon, Inc. 52
Clinical Trial Overview of Cephalon, Inc. 52
Supernus Pharmaceuticals, Inc. 53
Clinical Trial Overview of Supernus Pharmaceuticals, Inc. 53
Pfizer Inc. 54
Clinical Trial Overview of Pfizer Inc. 54
Noven Pharmaceuticals, Inc. 55
Clinical Trial Overview of Noven Pharmaceuticals, Inc. 55
Medice Arzneimittel Putter GmbH & Co. KG 56
Clinical Trial Overview of Medice Arzneimittel Putter GmbH & Co. KG 56
Alcobra Ltd 57
Clinical Trial Overview of Alcobra Ltd 57
Sunovion Pharmaceuticals Inc. 58
Clinical Trial Overview of Sunovion Pharmaceuticals Inc. 58
Alza Corporation 59
Clinical Trial Overview of Alza Corporation 59
Merck & Co., Inc. 60
Clinical Trial Overview of Merck & Co., Inc. 60
Ortho-McNeil-Janssen Pharmaceuticals, Inc. 61
Clinical Trial Overview of Ortho-McNeil-Janssen Pharmaceuticals, Inc. 61
Yuyu Pharma, Inc. 62
Clinical Trial Overview of Yuyu Pharma, Inc. 62
Eisai Inc. 63
Clinical Trial Overview of Eisai Inc. 63
Teva Pharmaceuticals USA, Inc. 64
Clinical Trial Overview of Teva Pharmaceuticals USA, Inc. 64
Clinical Trial Overview of Top Universities / Institutes / Hospitals 65
Massachusetts General Hospital 65
Clinical Trial Overview of Massachusetts General Hospital 65
National Taiwan University Hospital 68
Clinical Trial Overview of National Taiwan University Hospital 68
Cincinnati Children’s Hospital Medical Center 70
Clinical Trial Overview of Cincinnati Children’s Hospital Medical Center 70
Tehran University of Medical Sciences 71
Clinical Trial Overview of Tehran University of Medical Sciences 71
New York State Psychiatric Institute 72
Clinical Trial Overview of New York State Psychiatric Institute 72
Hadassah Medical Organization 73
Clinical Trial Overview of Hadassah Medical Organization 73
The University of British Columbia 74
Clinical Trial Overview of The University of British Columbia 74
King’s College London 75
Clinical Trial Overview of King’s College London 75
Duke University 76
Clinical Trial Overview of Duke University 76
University of Cincinnati 77
Clinical Trial Overview of University of Cincinnati 77
University of Pittsburgh 78
Clinical Trial Overview of University of Pittsburgh 78
University of Cologne 79
Clinical Trial Overview of University of Cologne 79
The Federal University of Rio Grande do Sul 80
Clinical Trial Overview of The Federal University of Rio Grande do Sul 80
University of California, Irvine 81
Clinical Trial Overview of University of California, Irvine 81
UMC Utrecht Holding BV 82
Clinical Trial Overview of UMC Utrecht Holding BV 82
New York University School of Medicine 83
Clinical Trial Overview of New York University School of Medicine 83
Shaare Zedek Medical Center 84
Clinical Trial Overview of Shaare Zedek Medical Center 84
Shalvata Mental Health Center 85
Clinical Trial Overview of Shalvata Mental Health Center 85
Peking University 86
Clinical Trial Overview of Peking University 86
Utrecht University 87
Clinical Trial Overview of Utrecht University 87
Five Key Clinical Profiles 88
Appendix 171
Abbreviations 171
Definitions 171
Research Methodology 173
Secondary Research 173
About GlobalData 174
Contact Us 174
Disclaimer 174
Source 175


【レポート販売概要】

■ タイトル:Attention Deficit Hyperactivity Disorder (ADHD):グローバル臨床試験レビューH1, 2013
■ 英文:Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2013
■ 発行日:2013年3月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160595
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。